Ingenito Gary Insider Trades

Insider Trading History

Track insider trading activity for Ingenito Gary. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $3.55M 112,873 shares
Last Trade
May 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 44,000 shares
$23.40
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $17.2M 546,282 shares
Last Trade
May 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 44,000 shares
$23.40
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.17M 68,873 shares
Last Trade
May 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04M 44,000 shares
$23.63
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.17M 68,873 shares
Last Trade
May 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.74M 200,000 shares
$23.68
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $18.6M 590,282 shares
Last Trade
May 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.73M 200,000 shares
$23.65
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $8.47M 268,873 shares
Last Trade
May 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.73M 200,000 shares
$23.65
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $24.9M 790,282 shares
Last Trade
Mar 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.9M 180,096 shares
$21.67
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $7.84M 248,969 shares
Last Trade
Mar 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.9M 180,096 shares
$21.67
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.17M 68,873 shares
Last Trade
Mar 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.9M 180,096 shares
$21.67
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $30.6M 970,378 shares
Last Trade
Mar 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$983k 44,904 shares
$21.89
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.17M 68,873 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$992k 44,904 shares
$22.09
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $3.58M 113,777 shares
Last Trade
Mar 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$983k 44,904 shares
$21.89
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.25M 71,308 shares
Last Trade
Feb 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$233k 10,000 shares
$23.27
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $32M 1,015,282 shares
Last Trade
Feb 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$233k 10,000 shares
$23.27
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.17M 68,873 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$56.7k 2,435 shares
$23.27
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $32.3M 1,025,282 shares
Last Trade
Dec 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 9,000 shares
$21.47
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $2.04M 64,849 shares
Last Trade
Dec 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 9,000 shares
$21.47
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $1.93M 61,308 shares
Last Trade
Dec 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76k 3,541 shares
$21.47
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $32.6M 1,034,282 shares
Last Trade
Dec 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 7,349 shares
$21.74
$31.49
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Med. & Reg. Officer
Holding Value $1.85M 58,740 shares
Last Trade
Dec 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$160k 7,349 shares
$21.74
$31.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up